149 related articles for article (PubMed ID: 23786462)
1. Reversal of cardiomyopathy with tocilizumab in a case of HIV-negative Castleman's disease.
Man L; Goudar RK
Eur J Haematol; 2013 Sep; 91(3):273-276. PubMed ID: 23786462
[TBL] [Abstract][Full Text] [Related]
2. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
[TBL] [Abstract][Full Text] [Related]
4. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
Matsuyama M; Suzuki T; Tsuboi H; Ito S; Mamura M; Goto D; Matsumoto I; Tsutsumi A; Sumida T
Intern Med; 2007; 46(11):771-4. PubMed ID: 17541233
[TBL] [Abstract][Full Text] [Related]
5. Multicentric Castleman's disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report.
Oshima Y; Hoshino J; Suwabe T; Hayami N; Yamanouchi M; Sekine A; Ueno T; Mizuno H; Yabuuchi J; Imafuku A; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Hayashi N; Fujii T; Ubara Y
Clin Rheumatol; 2017 Mar; 36(3):729-733. PubMed ID: 28168662
[TBL] [Abstract][Full Text] [Related]
6. A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease.
Koga T; Sumiyoshi R; Kawakami A; Yoshizaki K
Mod Rheumatol; 2019 Mar; 29(2):302-305. PubMed ID: 30285516
[TBL] [Abstract][Full Text] [Related]
7. A comorbid case of multicentric Castleman's disease and pulmonary hyalinising granuloma successfully treated with tocilizumab and corticosteroid.
Takeuchi N; Arai T; Kitaichi M; Inoue Y
BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24072826
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease.
Ebisawa K; Masamoto Y; Tokushige J; Nishi H; Honda K; Hinata M; Toyama K; Nangaku M; Kurokawa M
Ann Hematol; 2019 Aug; 98(8):1995-1997. PubMed ID: 30761408
[No Abstract] [Full Text] [Related]
9. Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis.
Awano N; Inomata M; Kondoh K; Satake K; Kamiya H; Moriya A; Ando T; Kumasaka T; Takemura T; Takeuchi K; Ikushima S
Intern Med; 2012; 51(21):3061-6. PubMed ID: 23124151
[TBL] [Abstract][Full Text] [Related]
10. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
[TBL] [Abstract][Full Text] [Related]
11. Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody.
Kanda J; Kawabata H; Yamaji Y; Ichinohe T; Ishikawa T; Tamura T; Furukawa Y; Kimura T; Kita T; Uchiyama T
Int J Hematol; 2007 Apr; 85(3):207-11. PubMed ID: 17483056
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of a mesangial proliferative glomerulonephritis with interstitial nephritis associated with Castleman's disease by an anti-interleukin-6 receptor antibody (tocilizumab).
Otani N; Morishita Y; Oh I; Saito O; Takemoto F; Muto S; Kusano E
Intern Med; 2012; 51(11):1375-8. PubMed ID: 22687845
[TBL] [Abstract][Full Text] [Related]
13. [Dyspnoea, cough and B symptoms in a 40-year-old woman].
Wolfensberger A; Benz R; Russi EW; Tinguely M; Keller C; Gerber B
Internist (Berl); 2013 Aug; 54(8):1011-5. PubMed ID: 23836253
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman's disease.
Arita Y; Sakata Y; Sudo T; Maeda T; Matsuoka K; Tamai K; Higuchi K; Shioyama W; Nakaoka Y; Kanakura Y; Yamauchi-Takihara K
Heart Vessels; 2010 Sep; 25(5):444-7. PubMed ID: 20676969
[TBL] [Abstract][Full Text] [Related]
15. A case of multicentric Castleman's disease having lung lesion successfully treated with humanized anti-interleukin-6 receptor antibody, tocilizumab.
Higuchi T; Nakanishi T; Takada K; Matsumoto M; Okada M; Horikoshi H; Suzuki K
J Korean Med Sci; 2010 Sep; 25(9):1364-7. PubMed ID: 20808682
[TBL] [Abstract][Full Text] [Related]
16. Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report.
Cai S; Zhong Z; Li X; Wang HX; Wang L; Zhang M
Medicine (Baltimore); 2019 Nov; 98(46):e17681. PubMed ID: 31725610
[TBL] [Abstract][Full Text] [Related]
17. IL-6-positive classical Hodgkin's lymphoma co-occurring with plasma cell type of Castleman's disease: report of a case.
Momoi A; Kojima M; Sakai T; Ajiro J; Isahai N; Nagai K; Aoki S
Int J Hematol; 2013 Feb; 97(2):275-9. PubMed ID: 23359301
[TBL] [Abstract][Full Text] [Related]
18. [Tocilizumab treatment of HHV8-positive/HIV-negative, multricentric plasma cell type Castleman's disease].
Mûzes G; Csomor J; Sipos F
Magy Onkol; 2016 Nov; 60(4):328-332. PubMed ID: 27898752
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.
Pan Y; Cui Z; Wang S; Zheng D; Deng Z; Tian X; Guo H; Bao W; Zhou S; Wang Y
BMC Nephrol; 2020 Dec; 21(1):528. PubMed ID: 33276741
[TBL] [Abstract][Full Text] [Related]
20. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.
van Rhee F; Wong RS; Munshi N; Rossi JF; Ke XY; Fosså A; Simpson D; Capra M; Liu T; Hsieh RK; Goh YT; Zhu J; Cho SG; Ren H; Cavet J; Bandekar R; Rothman M; Puchalski TA; Reddy M; van de Velde H; Vermeulen J; Casper C
Lancet Oncol; 2014 Aug; 15(9):966-74. PubMed ID: 25042199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
